echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > How brain cells die in prion diseases

    How brain cells die in prion diseases

    • Last Update: 2022-01-07
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The accumulation of protein in axons, as well as other signs of axon swelling and dysfunction, are also early features of other neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease


    "We hope that these findings will lead to a better understanding of prions and other neurodegenerative diseases, as well as new strategies to treat them," said Dr.


    In their study, the researchers carefully observed the mutant pathogenic copies of the prion disease protein PrP.


    The researchers also discovered a key protein complex that is responsible for guiding PrP to axons and causing aggregation associated with axon swelling


    Fragile axons

    Creutzfeldt-Jakob disease is the most common prion disease in humans, with about one case per million people in the world every year


    In this study, Encalada's team used mouse brain cells containing mutant PrP and film technology under the microscope to study the initial accumulation of PrP in axons


    The normal function of PrP in neurons has been unclear, but this protein seems to be normally secreted from somatic cells and axons through sac-like containers called vesicles, and is sometimes recovered or degraded in axons.


    This movement involves a somewhat complicated vesicle transport system.


    Researchers have also discovered a way to combat the formation of endoderm


    This result shows a fascinating possibility that prion diseases, as well as many other protein-aggregating diseases in the brain, can be achieved by at least temporarily interrupting the transport of vesicle-encapsulated, aggregated proteins to axons.


    Encalada said: "We are very keen to discover molecules that can inhibit this aggregation formation pathway, and to study the role of these inhibitors in animal models of prions and other neurodegenerative diseases



    Journal Reference :

    1. Romain Chassefeyre, Tai Chaiamarit, Adriaan Verhelle, Sammy Weiser Novak, Leonardo R.



    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.